Rx Incurin 1mg 30 Count Tablet

Incurin Tablets Incurin Tablets are an effective treatment for the control of estrogen-responsive urinary incontinence in dogs that have undergone surgical removal of the ovaries and uterus (ovariohysterectomy). - CAUTIONS/WARNINGS:Human Warnings: Not for human use. Keep out of the reach of children. Women who are of child-bearing age or those who are breastfeeding should use caution when administering INCURIN Tablets. Wash your hands with soap and water after administration to avoid exposure to the drug. Consult a physician in case of accidental ingestion by humans. Animal Warnings: Some estrogens have been associated with bone marrow changes and an increased risk of mammary tumors. However target animal safety study results and foreign post-market pharmacovigilance data for INCURIN Tablets have shown that estriol-treated dogs are at low risk for developing these conditions. - DIRECTIONS:Incurin Tablets Dosage: Incurin Tablets Initial Dosage for Dogs All Weight: 2 mg Incurin Tablets (2 tablets) orally once per day for a minimum of 14 days, or as directed by your veterinarian. Incurin Tablets Maintenance Dosage for Dogs All Weight: Dosage should be determined by decreasing the dose in a step-wise manner from 2 mg once daily (2 tablets) to 1 mg once daily (1 tablet), then 0.5 mg once daily (1/2 tablet), or as directed by your veterinarian. - INGREDIENTS:Ingredients: Incurin Tablets 1 mg: Estriol....1 mg - MATERIAL/COMP:Solid (e.g. Chews Tablet Toy) - STORAGE/DISPOSAL REQ:Store at 59-77 degrees F - HEIGHT(INCHES): 1.000 - WIDTH(INCHES):1.000 - LENGTH(INCHES):1.000

Ingredients

1 mg of estriol per tablet.

Dosage & Directions

The dose of INCURIN Tablets is not dependent upon body weight. All dogs should receive an initial dose of 2 mg INCURIN Tablets (2 tablets) orally once per day for a minimum of 14 days. After urinary incontinence is controlled, the lowest effective daily dose of INCURIN Tablets should be determined by decreasing the dose in a step-wise manner from 2 mg once daily (2 tablets) to 1 mg once daily (1 tablet), then 0.5?mg once daily (1/2 tablet) depending upon the response of the individual dog. There should be a minimum of 7 days between each dose adjustment. After the lowest daily dose that controls urinary incontinence is identified, the dose may be decreased further by administering once every two days. Dogs should not receive more than 2 mg INCURIN Tablets per day (2?tablets). If the dog does not respond to 2 mg of INCURIN Tablets per day, the diagnosis should be re-assessed.

Cautions & Warnings

Human Warnings: Not for human use. Keep out of the reach of children. Women who are of child-bearing age or those who are breastfeeding should use caution when administering INCURIN Tablets. Wash your hands with soap and water after administration to avoid exposure to the drug. Consult a physician in case of accidental ingestion by humans. Animal Warnings: Some estrogens have been associated with bone marrow changes and an increased risk of mammary tumors. However, target animal safety study results and foreign post-market pharmacovigilance data for INCURIN Tablets have shown that estriol-treated dogs are at low risk for developing these conditions.